thromboxane-a2 and Cushing-Syndrome

thromboxane-a2 has been researched along with Cushing-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for thromboxane-a2 and Cushing-Syndrome

ArticleYear
Haemostatic parameters in Cushing's syndrome.
    Acta medica Scandinavica, 1985, Volume: 217, Issue:5

    We have studied haemostatic parameters in 12 patients with Cushing's syndrome. Three patients had prolonged bleeding times, and in all seven patients whose bleeding times were measured 3-6 months after surgical treatment the postoperative bleeding times were shorter (mean 7.5 min) than the pretreatment times (mean 12.3 min). In ADP- or adrenaline-induced aggregation the second wave was lacking in six and the degree of aggregation was borderline or subnormal in five patients. One patient had, in addition, a severe defect in collagen-induced aggregation. However, thromboxane B2 production of the platelets from both endogenous and exogenous arachidonic acid was unaffected. Factor VIII:C, RAg and Rcof activities were all elevated, and in patients with severe disease F VIIIR:Ag and F VIII:Rcof activities were markedly more elevated than F VIII:C activity. The changes in both primary haemostasis and in factor VIII activities correlated clearly with the clinical severity of the disease.

    Topics: Adolescent; Adult; Bleeding Time; Blood Platelets; Cushing Syndrome; Female; Hemostasis; Humans; Male; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Thromboxanes

1985